Targeting HER2-positive breast cancer: advances and future directions
Georgetown University · Georgetown University Medical Center · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,051
total citations
- FWCI
- 96.62
- Percentile
- 100%
- References
- 297
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Trastuzumab
- Medicine
- Breast cancer
- Targeted therapy
- Monoclonal antibody
- Clinical trial
- Cancer
- Drug
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.